Amaroq Therapeutics

Developing first-in-class therapies to precisely target disease-driving long non-coding RNAs (lncRNAs) in oncology and beyond

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Developing first-in-class therapies to precisely target disease-driving long non-coding RNAs (lncRNAs) in oncology and beyond.

02Backed By1 investor

03Similar Companies

AP

ADARx Pharmaceuticals

Biotech & Life Sciences

→

ST

BT

WL

KB

04Startup DNA

8

signals

Sectors
Business Model
Technology